The Use of Lurbinectedin for the Treatment of Small Cell and Neuroendocrine Carcinoma of the Prostate-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Use of Lurbinectedin for the Treatment of Small Cell and Neuroendocrine Carcinoma of the Prostate

Published:2024-10 Issue:5 Volume:22 Page:102172
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Meyer Haley^ORCID,Sunkara Rajitha,Rothmann Emily,Shah Amar,Riaz Irbaz,Courtney Kevin Dale,Armstrong Andrew J.,Lippucci Andrea,Naqvi Syed Arsalan Ahmed,Stanton Melissa L.,Beltran Himisha,Bryce Alan Haruo^ORCID

Publisher

Elsevier BV

Reference30 articles.

1. Not such a small diagnosis: small cell carcinoma of the prostate;Rauf;J Surg Case Rep,2020

2. Lurbinectedin: first approval;Markham;Drugs,2020

3. Nccn.org. Published 2020. Accessed February 1, 2023. https://www.nccn.org/professionals/physician_gls/pdf/prostate.pdf

4. An overview of lurbinectedin as a new second-line treatment option for small cell lung cancer;Patel;Ther Adv Med Oncol,2021

5. Small Cell (Oat Cell) cancer of the prostate. Program operations manual system (POMS). 2020. Accessed February 25, 2023. http://policy.ssa.gov/poms.nsf/lnx/0423022310

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP